These data elucidated that high SNHG1 expression could be used as a novel predictive biomarker of poor prognosis in colorectal cancer and might be a potential therapeutic target for diagnosis and therapy of CRC. This evidence concerns the gene SNHG1 and colorectal carcinoma.